Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Mueller

Showing results (91-100 of 223) with videos related to

Pageof 23
Sort By:
NPJ Precision Oncology|July 2, 2025
Dual treatment with Val-083 and AZD1775 shows potent anti-tumor activity in diffuse midline glioma modelsBavani Subramaniam, Debasish Roy, Ayda Woldegerima, et al.
Neoplasia (New York, N.Y.)|February 4, 2023
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagementAngela Waanders, Alex Brown, Nadine R Caron, et al.
Neuro-Oncology Advances|October 20, 2023
Evolution and implementation of radiographic response criteria in neuro-oncologyDivya Ramakrishnan, Marc von Reppert, Mark Krycia, et al.
Neuro-Oncology|February 15, 2011
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomideGautam Prasad, Theo Sottero, Xiaodong Yang, et al.
Cancer|December 7, 2019
Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor StudySabine Mueller, Cassie N Kline, Robin A Buerki, et al.
Neuro-Oncology Advances|June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium studySabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.
Neuro-Oncology|March 6, 2024
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse gliomaIsabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, et al.
Journal of Neuro-Oncology|October 26, 2016
Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patientsDavid R Raleigh, Bryan Tomlin, Benedict Del Buono, et al.
Neuro-Oncology|December 6, 2013
Targeting Wee1 for the treatment of pediatric high-grade gliomasSabine Mueller, Rintaro Hashizume, Xiaodong Yang, et al.
Neuro-Oncology|July 4, 2012
PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcomeSabine Mueller, Joanna Phillips, Arzu Onar-Thomas, et al.
Pageof 23

Showing results (91-100 of 223) with videos related to

Sort By:
Pageof 23
NPJ Precision Oncology|July 2, 2025
Dual treatment with Val-083 and AZD1775 shows potent anti-tumor activity in diffuse midline glioma modelsBavani Subramaniam, Debasish Roy, Ayda Woldegerima, et al.
Neoplasia (New York, N.Y.)|February 4, 2023
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagementAngela Waanders, Alex Brown, Nadine R Caron, et al.
Neuro-Oncology Advances|October 20, 2023
Evolution and implementation of radiographic response criteria in neuro-oncologyDivya Ramakrishnan, Marc von Reppert, Mark Krycia, et al.
Neuro-Oncology|February 15, 2011
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomideGautam Prasad, Theo Sottero, Xiaodong Yang, et al.
Cancer|December 7, 2019
Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor StudySabine Mueller, Cassie N Kline, Robin A Buerki, et al.
Neuro-Oncology Advances|June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium studySabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.
Neuro-Oncology|March 6, 2024
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse gliomaIsabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, et al.
Journal of Neuro-Oncology|October 26, 2016
Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patientsDavid R Raleigh, Bryan Tomlin, Benedict Del Buono, et al.
Neuro-Oncology|December 6, 2013
Targeting Wee1 for the treatment of pediatric high-grade gliomasSabine Mueller, Rintaro Hashizume, Xiaodong Yang, et al.
Neuro-Oncology|July 4, 2012
PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcomeSabine Mueller, Joanna Phillips, Arzu Onar-Thomas, et al.
Pageof 23